Funder: Florida James and Esther King Biomedical Research Program
Due Dates (Anticipated): September 2027 (LOI) | October 2027 (Application)
Funding Amounts: Up to $100,000–$1,500,000 by category, including direct and indirect costs; maximum durations of 6–48 months
Summary: Supports biomedical research addressing tobacco-related cancer, cardiovascular disease, stroke, and pulmonary disease affecting Floridians.
Key Information: The designated PI must be an employee of the applicant and a U.S. citizen or permanent resident.
Description
The James and Esther King Biomedical Research Program is administered by the Florida Department of Health’s Biomedical Research Section, with advice from the Biomedical Research Advisory Council (BRAC). It supports research to improve prevention, diagnosis, treatment, and cures for tobacco-related cancer, cardiovascular disease, stroke, and pulmonary disease affecting Floridians.
The program funds basic science, clinical and behavioral research, emerging technologies, infrastructure, equipment, and investigator development. Priorities include tobacco-use prevention and reduction, electronic-cigarette research, reduced morbidity and mortality, improved screening, treatment resistance, and obesity’s relationship to cancer. Broader goals include integrating research advances into health-professional training, attracting research funding from outside Florida, and supporting biomedical economic activity.
